Congress takes aim at prescription drug costs in hearing but gets sidetracked by ACA repeal bill

A bipartisan Senate health committee held the first of three hearings on the rising costs of prescription drugs but didn’t get very far. In many ways it became a gripe session for Democrats over their Republican counterparts’ closed-door session and secret meetings about their healthcare reform replacement bill.

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive